BB&T Investment Services Inc. Takes $144,000 Position in Zimmer Biomet Holdings, Inc. (ZBH)

BB&T Investment Services Inc. bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 1,013 shares of the medical equipment provider’s stock, valued at approximately $144,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Enterprise Financial Services Corp boosted its stake in shares of Zimmer Biomet Holdings by 0.3% during the 2nd quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock worth $340,000 after acquiring an additional 9 shares during the period. Sandy Spring Bank boosted its stake in Zimmer Biomet Holdings by 1.7% in the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after purchasing an additional 20 shares during the period. Cleararc Capital Inc. boosted its stake in Zimmer Biomet Holdings by 0.5% in the 1st quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after purchasing an additional 25 shares during the period. Parkside Financial Bank & Trust boosted its stake in Zimmer Biomet Holdings by 3.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after purchasing an additional 33 shares during the period. Finally, CWA Asset Management Group LLC boosted its stake in Zimmer Biomet Holdings by 1.8% in the 2nd quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock valued at $251,000 after purchasing an additional 34 shares during the period. Institutional investors own 85.36% of the company’s stock.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded down 0.72% during trading on Friday, hitting $119.76. The stock had a trading volume of 186,814 shares. The stock has a market capitalization of $24.21 billion, a P/E ratio of 34.11 and a beta of 1.19. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The company has a 50-day moving average of $115.79 and a 200-day moving average of $120.39.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. Zimmer Biomet Holdings’s quarterly revenue was up 1.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.02 EPS. On average, equities analysts expect that Zimmer Biomet Holdings, Inc. will post $8.23 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.80%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is 27.59%.

Several research firms recently issued reports on ZBH. Morgan Stanley boosted their price target on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, July 17th. Piper Jaffray Companies restated a “buy” rating and issued a $141.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Stifel Nicolaus restated a “hold” rating and issued a $125.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Bank of America Corporation restated a “buy” rating and issued a $158.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $140.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $136.55.

In related news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.07% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “BB&T Investment Services Inc. Takes $144,000 Position in Zimmer Biomet Holdings, Inc. (ZBH)” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/10/13/bbt-investment-services-inc-takes-144000-position-in-zimmer-biomet-holdings-inc-zbh.html.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply